Healthcare - Biotechnology - NASDAQ - US
$ 2.67
-4.98 %
$ 755 M
Market Cap
-2.87
P/E
Price Target
Average
162.17%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
10.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Erasca, Inc.
Wall Street analysts predict an average 1-year price target for ERAS of $7 , with forecasts ranging from a low of $7 to a high of $7 .
ERAS Lowest Price Target
Wall Street Target
7 USD
162.17%
ERAS Average Price Target
Wall Street Target
7 USD
162.17%
ERAS Highest Price Target
Wall Street Target
7 USD
162.17%
REVENUE FORECAST
Revenue Forecast Chart ERAS
EBIT FORECAST
EBIT Forecast Chart ERAS
NET INCOME FORECAST
Net Income Chart ERAS